Bronchipret TE® in therapy of acute infections of the respiratory tract
Bronchipret TE® exhibits multidirectional anti-inflammatory effects as demonstrated in vitro and in vivo studies. It has been disclosed that the drug has the ability to activate the bronchial cleaning mechanism, inhibit the respiratory tract remodeling process by reducing the number of goblet cells, inhibiting enzyme activity and proinflammatory mediators. These mechanisms cause the administration of medication to cause acute bronchitis patients to shorten and alleviate the course of the disease with rapid cough elimination. Use of Bronchipret TE® is in accordance with the recommendations of the European Guideline Committee's and the German Respiratory Society.
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego - 43(2017), 258 vom: 22. Dez., Seite 255-257 |
| Sprache: |
Polnisch |
|---|
| Weiterer Titel: |
Bronchipret TE® w leczeniu ostrych zakażeń układu oddechowego |
|---|
| Beteiligte Personen: |
Mastalerz-Migas, Agnieszka [VerfasserIn] |
|---|
| Themen: |
3J50XA376E |
|---|
| Anmerkungen: |
Date Completed 02.04.2018 Date Revised 05.04.2022 published: Print Citation Status MEDLINE |
|---|
| Förderinstitution / Projekttitel: |
|
|---|
| PPN (Katalog-ID): |
NLM279620950 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279620950 | ||
| 003 | DE-627 | ||
| 005 | 20231225023413.0 | ||
| 007 | tu | ||
| 008 | 231225s2017 xx ||||| 00| ||pol c | ||
| 028 | 5 | 2 | |a pubmed24n0932.xml |
| 035 | |a (DE-627)NLM279620950 | ||
| 035 | |a (NLM)29298963 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a pol | ||
| 100 | 1 | |a Mastalerz-Migas, Agnieszka |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bronchipret TE® in therapy of acute infections of the respiratory tract |
| 246 | 3 | 3 | |a Bronchipret TE® w leczeniu ostrych zakażeń układu oddechowego |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a Date Completed 02.04.2018 | ||
| 500 | |a Date Revised 05.04.2022 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Bronchipret TE® exhibits multidirectional anti-inflammatory effects as demonstrated in vitro and in vivo studies. It has been disclosed that the drug has the ability to activate the bronchial cleaning mechanism, inhibit the respiratory tract remodeling process by reducing the number of goblet cells, inhibiting enzyme activity and proinflammatory mediators. These mechanisms cause the administration of medication to cause acute bronchitis patients to shorten and alleviate the course of the disease with rapid cough elimination. Use of Bronchipret TE® is in accordance with the recommendations of the European Guideline Committee's and the German Respiratory Society | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a Bronchipret | |
| 650 | 4 | |a bronchitis | |
| 650 | 4 | |a cough | |
| 650 | 7 | |a Anti-Inflammatory Agents, Non-Steroidal |2 NLM | |
| 650 | 7 | |a thyme extract and ivy extract drug combination |2 NLM | |
| 650 | 7 | |a Thymol |2 NLM | |
| 650 | 7 | |a 3J50XA376E |2 NLM | |
| 700 | 1 | |a Doniec, Zbigniew |e verfasserin |4 aut | |
| 700 | 1 | |a Płusa, Tadeusz |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego |d 1997 |g 43(2017), 258 vom: 22. Dez., Seite 255-257 |w (DE-627)NLM090955315 |x 1426-9686 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2017 |g number:258 |g day:22 |g month:12 |g pages:255-257 |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2017 |e 258 |b 22 |c 12 |h 255-257 | ||